Penicillin Reactions in Patients With Severe Rheumatic Heart Disease: A Presidential Advisory From the American Heart Association

Written By RRCU Staff

Amy Sanyahumbi, MD, Chair; Sulafa Ali, FRCPCH; Ivor J. Benjamin, MD, FAHA; Ganesan Karthikeyan, MBBS, MD, DM, MSc; Emmy Okello, MD, PhD; Craig A. Sable, MD, FAHA; Kathryn Taubert, PhD, FAHA; Rosemary Wyber, MBChB, MPH, FRACGP; Liesl Zuhlke, MBCHB, DCH, FCPaeds Cert Card, MPH, MSc, PhD; Jonathan R. Carapetis, MD, PhD; Andrea Z. Beaton, MD

J Am Heart Assoc. 2022;11:e024517.

RRCU Staff
Previous

Comparison of approaches to determine echocardiographic outcomes for children with latent rheumatic heart disease
Next

Positive impact of training rural health workers in identification and prevention of acute rheumatic fever in eastern Uganda